sulfonylurea vs glp 1 Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar GLP1 Receptor Agonists vs SGLT2-I
Description
To date, no desensitization protocol with GLP-1 receptor agonists has been reported
GLP-1 agonists arent likely to cause low blood sugar levels or hypoglycemia when used alone
The health benefits for infants, reduced infections, improved immune function, potential long-term metabolic benefits, are well established
Update prior authorization processes to include generic options
Small trials, reports from patients and clinicians, and retrospective studies all point to a powerful anti-addictive effect
